Literature DB >> 4596238

Diphenylhydantoin as an antiarrhythmic drug.

A J Atkinson, R Davison.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4596238     DOI: 10.1146/annurev.me.25.020174.000531

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


× No keyword cloud information.
  8 in total

Review 1.  Treatment of cardiac arrhythmias during pregnancy: safety considerations.

Authors:  J A Joglar; R L Page
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

2.  Type 1 Brugada pattern ECG due to supra-therapeutic phenytoin level.

Authors:  Thein Swe; Bikash Bhattarai; Alix Dufresne
Journal:  BMJ Case Rep       Date:  2016-06-28

Review 3.  Prodrugs. Do they have advantages in clinical practice?

Authors:  V J Stella; W N Charman; V H Naringrekar
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

Review 4.  Phenytoin poisoning.

Authors:  Simon Craig
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

5.  [Plasma concentrations after injection or infusion of phenytoin (author's transl)].

Authors:  D Schmidt; A Vogel
Journal:  Klin Wochenschr       Date:  1977-03-01

6.  Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.

Authors:  J L Anderson; D C Harrison; P J Meffin; R A Winkle
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

Review 7.  The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.

Authors:  G M Mitani; I Steinberg; E J Lien; E C Harrison; U Elkayam
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

8.  Evidence against an involvement of Na+, K+-ATPase in antiarrhythmic mechanism of phenytoin.

Authors:  H M Rhee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.